BioInfra Life Science Inc. (XKON:266470)
South Korea · Delayed Price · Currency is KRW 95.00
-3.00 (-3.06%)
At close: Oct 23, 2026
BioInfra Life Science Revenue
BioInfra Life Science had revenue of 146.99M KRW in the quarter ending March 31, 2020, a decrease of -39.41%. This brings the company's total for the last twelve months to 1.78B, up 27.54% year-over-year. In the year 2019, BioInfra Life Science had annual revenue of 1.87B with 20.83% growth. That makes BioInfra Life Science the 43,104th largest company in the world by revenue and 2,576th in South Korea.
Revenue (ttm)
1.78B
Revenue Growth
+27.54%
P/S Ratio
1.16
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.06B
Revenue by Geography
- South Korea 1.84B 98.0%
- Overseas 36.77M 2.0%
Fiscal year ended Dec 31, 2019
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2019 | 1.87B | 323.09M | 20.83% |
| Dec 31, 2018 | 1.55B | 181.52M | 13.25% |
| Dec 31, 2017 | 1.37B | -179.77M | -11.60% |
| Dec 31, 2016 | 1.55B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.